137 related articles for article (PubMed ID: 2032737)
21. Detection of transforming ras proteins containing leucine at position 61 by a new mouse monoclonal antibody, ras(53-69)Leu61.
Bizub D; Fischberg-Bender E; Heimer EP; Felix A; Skalka AM
Cancer Res; 1989 Nov; 49(22):6425-31. PubMed ID: 2680065
[TBL] [Abstract][Full Text] [Related]
22. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter.
Thompson TA; Haag JD; Lindstrom MJ; Griep AE; Lohse JK; Gould MN
Oncogene; 2002 Apr; 21(18):2797-804. PubMed ID: 11973638
[TBL] [Abstract][Full Text] [Related]
23. Effect of tamoxifen on preneoplastic cell proliferation in N-nitroso-N-methylurea-induced mammary carcinogenesis.
Osborne MP; Ruperto JF; Crowe JP; Rosen PP; Telang NT
Cancer Res; 1992 Mar; 52(6):1477-80. PubMed ID: 1540955
[TBL] [Abstract][Full Text] [Related]
24. Absence of Ras mutations in rat DMBA-induced mammary tumors.
Samuelson E; Nilsson J; Walentinsson A; Szpirer C; Behboudi A
Mol Carcinog; 2009 Feb; 48(2):150-5. PubMed ID: 18649354
[TBL] [Abstract][Full Text] [Related]
25. Infrequent activation of K-ras, H-ras, and other oncogenes in hepatocellular neoplasms initiated by methyl(acetoxymethyl)nitrosamine, a methylating agent, and promoted by phenobarbital in F344 rats.
Watatani M; Perantoni AO; Reed CD; Enomoto T; Wenk ML; Rice JM
Cancer Res; 1989 Mar; 49(5):1103-9. PubMed ID: 2645046
[TBL] [Abstract][Full Text] [Related]
26. Mutational activation of c-Ha-ras genes in intraductal proliferation induced by N-nitroso-N-methylurea in rat mammary glands.
Sakai H; Ogawa K
Int J Cancer; 1991 Aug; 49(1):140-4. PubMed ID: 1874567
[TBL] [Abstract][Full Text] [Related]
27. Immunocytochemical localization of RasHa p21 in normal and neoplastic cells in fixed tissue sections from Harvey sarcoma virus-infected mice.
Ward JM; Pardue RL; Junker JL; Takahashi K; Shih TY; Weislow OS
Carcinogenesis; 1986 Apr; 7(4):645-51. PubMed ID: 3516433
[TBL] [Abstract][Full Text] [Related]
28. Peptide-specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21.
Abrams SI; Dobrzanski MJ; Wells DT; Stanziale SF; Zaremba S; Masuelli L; Kantor JA; Schlom J; Masuelle L [corrected to Masuelli L]
Eur J Immunol; 1995 Sep; 25(9):2588-97. PubMed ID: 7589131
[TBL] [Abstract][Full Text] [Related]
29. Ha-ras-1 oncogene mutations in mammary epithelial cells do not contribute to initiation of spontaneous mammary tumorigenesis in rats.
Cha RS; Guerra L; Thilly WG; Zarbl H
Carcinogenesis; 1996 Nov; 17(11):2519-24. PubMed ID: 8968072
[TBL] [Abstract][Full Text] [Related]
30. Incidence of Harvey ras oncogene point mutations and their expression in methylbenzylnitrosamine-induced esophageal tumorigenesis.
Barch DH; Jacoby RF; Brasitus TA; Radosevich JA; Carney WP; Iannaccone PM
Carcinogenesis; 1991 Dec; 12(12):2373-7. PubMed ID: 1747941
[TBL] [Abstract][Full Text] [Related]
31. Isolation of oncogenes from rat mammary tumors by a highly efficient retrovirus expression cloning system.
Tsukamoto T; Huang T; Guzman RC; Chen X; Pascual RV; Kitamura T; Nandi S
Biochem Biophys Res Commun; 1999 Nov; 265(1):7-12. PubMed ID: 10548482
[TBL] [Abstract][Full Text] [Related]
32. Activation of H-ras oncogenes in preneoplastic mouse mammary tissues.
Kumar R; Medina D; Sukumar S
Oncogene; 1990 Aug; 5(8):1271-7. PubMed ID: 2118247
[TBL] [Abstract][Full Text] [Related]
33. ras oncogenes and phenotypic staging in N-methylnitrosourea- and gamma-irradiation-induced thymic lymphomas in C57BL/6J mice.
Newcomb EW; Steinberg JJ; Pellicer A
Cancer Res; 1988 Oct; 48(19):5514-21. PubMed ID: 3046741
[TBL] [Abstract][Full Text] [Related]
34. An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis.
Mangues R; Kahn JM; Seidman I; Pellicer A
Cancer Res; 1994 Dec; 54(24):6395-401. PubMed ID: 7987834
[TBL] [Abstract][Full Text] [Related]
35. Dietary N-3 fatty acids do not affect induction of Ha-ras mutations in mammary glands of NMU-treated rats.
Ronai Z; Lau YY; Cohen LA
Mol Carcinog; 1991; 4(2):120-8. PubMed ID: 2043252
[TBL] [Abstract][Full Text] [Related]
36. Establishment of four mouse hybridoma cell lines producing monoclonal antibodies reactive with ras oncogene product p21.
Kuzumaki N; Oda A; Yamagiwa S; Taniguchi N; Kobayashi H; Oikawa T
J Natl Cancer Inst; 1986 Dec; 77(6):1273-9. PubMed ID: 3540418
[TBL] [Abstract][Full Text] [Related]
37. Ras levels and metalloproteinase activity in normal versus neoplastic rat mammary tissues.
Ballin M; Mackay AR; Hartzler JL; Nason A; Pelina MD; Thorgeirsson UP
Clin Exp Metastasis; 1991; 9(2):179-89. PubMed ID: 2032422
[TBL] [Abstract][Full Text] [Related]
38. Characterization of an N-methyl-N-nitrosourea-induced autochthonous rat bladder cancer model.
Steinberg GD; Brendler CB; Ichikawa T; Squire RA; Isaacs JT
Cancer Res; 1990 Oct; 50(20):6668-74. PubMed ID: 2208131
[TBL] [Abstract][Full Text] [Related]
39. T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes.
Peace DJ; Chen W; Nelson H; Cheever MA
J Immunol; 1991 Mar; 146(6):2059-65. PubMed ID: 2005390
[TBL] [Abstract][Full Text] [Related]
40. Preparation, characterization and properties of monoclonal antibodies against intact H-ras p21 proteins.
Sorrentino V; Nebreda AR; Alonso T; Santos E
Oncogene; 1989 Feb; 4(2):215-22. PubMed ID: 2467247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]